RT Journal Article
SR Electronic
T1 Regression of peritoneal leiomyomatosis after treatment with gonadotropin releasing hormone analogue
JF International Journal of Gynecologic Cancer
JO Int J Gynecol Cancer
FD BMJ Publishing Group Ltd
SP 52
OP 54
DO 10.1046/j.1525-1438.1992.02010052.x
VO 2
IS 1
A1 F. F. NOGALES
A1 I. RUIZ-AVILA
A1 J. LINARES
A1 A. CONCHA
A1 P. A. CLAVERO
YR 1992
UL http://ijgc.bmj.com/content/2/1/52.abstract
AB A case of a 42-year-old woman with peritoneal leiomyomatosis (PL) unrelated to pregnancy or any other obvious hormonal source is presented. After treatment with leuprolide acetate for six months, a second-look operation revealed that the majority of the nodules totally regressed. The few remaining ones were substantially reduced in size and exhibited histopathologic evidence of fibrotic change. This response to treatment is documented here for the first time. Since this case was not associated with initial abnormally raised hormonal levels, the regression was caused solely by the treatment and not by the removal of any hormonal stimulus. The usefulness of GnRH analogues in the treatment of PL is proposed.